Home › Companies › Outset Medical, Inc. › 2025-2026

Outset Medical, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Outset Medical, Inc.’s Form 8-K, filed 2026-06-05 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 4Reported items
  • 115Asset managers
  • 514Fund votes
  • 2026-06-04Meeting date

Proxy season: 2023-2024 2025-2026

Explore Outset Medical, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Outset Medical, Inc.

These tallies are Outset Medical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Outset Medical, Inc. — official shareholder meeting results, meeting held 2026-06-04
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Brent D. Lang 8,109,357---- 2,642,6983,138,809 Majority: yes
Elect Director: Karen Prange 10,317,822---- 434,2333,138,809 Majority: yes

Source: Outset Medical, Inc., Form 8-K, filed with the SEC on 2026-06-05 — read the filing on EDGAR.

How asset managers voted at the Outset Medical, Inc. 2025-2026 meeting

Each item below shows how the 115 asset managers that disclosed a Outset Medical, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Outset Medical, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. TO APPROVE, ON A NON-BINDING BASIS, THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

81% fund support · no official result

FOR 81%AGAINST 19%

The 111 asset managers below cast 81% of the shares they voted on this item FOR (8,711,245 for, 1,989,258 against).

FOR: 8,711,245 (81.4%)AGAINST: 1,989,258 (18.6%)
Largest asset managers voting on “TO APPROVE, ON A NON-BINDING BASIS, THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at Outset Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity5,315,2130 00For
Vanguard966,8353,795 00For
BlackRock640,90422 00For
Ensign Peak Advisors, Inc526,3000 00For
PFM Health Sciences, LP0523,333 00Against
Invesco0512,754 00Against
GEODE CAPITAL MANAGEMENT, LLC421,3730 00For
AQR0358,251 00Against
State Street290,9612,471 00For
T. Rowe Price097,373 00Against
Northern Trust89,4215,036 00For
Dimensional092,400 00Against
Charles Schwab82,3240 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC75,8970 00For
GMT CAPITAL CORP70,1400 00For
C WorldWide Asset Management Fondsmaeglerselskab A/S066,666 00Against
Nuveen065,585 00Against
American Century053,886 00Against
MELLON INVESTMENTS Corp044,913 00Against
JPMorgan36,4900 00For
TIAA034,957 00Against
QUANTITATIVE MASTER SERIES LLC30,3330 00For
Goldman Sachs27,1460 00For
Woodline Partners LP24,0810 00For
ACADIAN ASSET MANAGEMENT LLC023,718 00Against

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

2. Election of Class III Directors: Brent D. Lang

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%WITHHELD 25%
FOR: 8,109,357WITHHELD: 2,642,698

Outset Medical, Inc.’s own tally for this item (“Elect Director: Brent D. Lang”): 8,109,357 for, 2,642,698 withheld, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 18,537,241 outstanding shares: 44% for, 14% withheld (58% of the company cast a for/withheld vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (4,248,176 for, 0 against).

FOR 96%
FOR: 4,248,176 (96.0%)ABSTAIN: 178,036 (4.0%)
Largest asset managers voting on “Election of Class III Directors: Brent D. Lang” at Outset Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity2,783,3640 00For
Vanguard850,5960 40For
BlackRock374,7800 00For
Dimensional00 82,8750Abstain
Charles Schwab41,1620 00For
AQR00 36,5030Abstain
JPMorgan36,4900 00For
TIAA34,9570 00For
QUANTITATIVE MASTER SERIES LLC30,3330 00For
American Century00 26,9430Abstain
Lincoln Financial21,7240 00For
Equitable12,9580 6,4000For
T. Rowe Price15,4640 00For
Goldman Sachs8,7560 00For
Global X8,2980 00For
AIG/SunAmerica00 7,6700Abstain
Bridge Builder Trust6,5200 00For
State Street5,8780 00For
Pacific Life5,7310 00For
Voya5,1210 00For
John Hancock00 3,7830Abstain
CLEARWATER INVESTMENT TRUST00 3,5250Abstain
SEI2,6000 00For
DWS00 2,4810Abstain
ProShares00 2,2620Abstain

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

3. Election of Class III Directors: Karen Prange

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 10,317,822WITHHELD: 434,233

Outset Medical, Inc.’s own tally for this item (“Elect Director: Karen Prange”): 10,317,822 for, 434,233 withheld, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 18,537,241 outstanding shares: 56% for, 2% withheld (58% of the company cast a for/withheld vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (4,410,747 for, 0 against).

FOR 99.6%
FOR: 4,410,747 (99.7%)ABSTAIN: 15,465 (0.3%)
Largest asset managers voting on “Election of Class III Directors: Karen Prange” at Outset Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity2,783,3640 00For
Vanguard850,5990 10For
BlackRock374,7800 00For
Dimensional82,8750 00For
Charles Schwab41,1620 00For
AQR36,5030 00For
JPMorgan36,4900 00For
TIAA34,9570 00For
QUANTITATIVE MASTER SERIES LLC30,3330 00For
American Century26,9430 00For
Lincoln Financial21,7240 00For
Equitable19,3580 00For
T. Rowe Price00 15,4640Abstain
Goldman Sachs8,7560 00For
Global X8,2980 00For
AIG/SunAmerica7,6700 00For
Bridge Builder Trust6,5200 00For
State Street5,8780 00For
Pacific Life5,7310 00For
Voya5,1210 00For
John Hancock3,7830 00For
CLEARWATER INVESTMENT TRUST3,5250 00For
SEI2,6000 00For
DWS2,4810 00For
ProShares2,2620 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

4. TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2026.

AUDIT-RELATED

100% fund support · no official result

FOR 99.9%

The 34 asset managers below cast 100% of the shares they voted on this item FOR (4,422,686 for, 0 against).

FOR: 4,422,686 (100.0%)ABSTAIN: 1 (0.0%)
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 202” at Outset Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity2,783,3640 00For
Vanguard850,5990 10For
BlackRock374,7800 00For
Dimensional82,8750 00For
Charles Schwab41,1620 00For
AQR36,5030 00For
JPMorgan36,4900 00For
TIAA34,9570 00For
QUANTITATIVE MASTER SERIES LLC30,3330 00For
American Century26,9430 00For
Lincoln Financial21,7240 00For
Equitable19,3580 00For
T. Rowe Price15,4640 00For
Goldman Sachs8,7560 00For
Global X8,2980 00For
AIG/SunAmerica7,6700 00For
Bridge Builder Trust6,5200 00For
State Street5,8780 00For
Pacific Life5,7310 00For
Voya5,1210 00For
John Hancock3,7830 00For
SEI2,6000 00For
DWS2,4810 00For
ProShares2,2620 00For
Calvert1,8090 00For

Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.

Largest Outset Medical, Inc. shareholders voting in 2025-2026

Ranked by the number of Outset Medical, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 18,537,241 shares outstanding at the time of that meeting.

Top Outset Medical, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 28.67%
2Vanguard 5.24%
3BlackRock 3.46%
4Ensign Peak Advisors, Inc 2.84%
5PFM Health Sciences, LP 2.82%
6Invesco 2.77%
7GEODE CAPITAL MANAGEMENT, LLC 2.27%
8AQR 1.93%
9State Street 1.58%
10T. Rowe Price 0.53%

Reported Outset Medical, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Outset Medical, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
FMR (Fidelity) 14.79% 13F
BML Investment Partners, L.P. 13.59% 13G
BlackRock 6.81% 13F
Vanguard Group 5.28% 13F
BANK OF AMERICA CORP /DE/ 3.60% 13G
PFM Health Sciences, LP 2.86% 13G
Geode Capital 2.27% 13F
Citadel Advisors 1.91% 13F
State Street 1.81% 13F
Woodline Partners LP 1.58% 13G

Percentages above are of 18,537,241 shares outstanding, as reported by Outset Medical, Inc. on its Form 10-Q dated 2026-05-01 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Outset Medical, Inc.’s 10-Q dated 2026-05-01. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Outset Medical, Inc.'s shareholder meeting held 2026-06-04, in the 2025-2026 proxy season, 115 asset managers reported how they voted in their SEC Form N-PX filings, covering 514 separate fund positions. Their filings are grouped here into 4 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Outset Medical, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — TO APPROVE, ON A NON-BINDING BASIS, THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — the reporting funds cast 81% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Outset Medical, Inc. proxy season coverage: 2023-2024 · 2025-2026 (this page).